array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2491) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(43) "The 3 Best Biotech Stocks to Buy in Q2 2024" ["snippet_en"]=> string(121) "Biotech can be a risky industry for investors, but we've done the legwork for you with these three biotech stocks for Q2." ["url"]=> string(78) "https://investorplace.com/2024/03/the-3-best-biotech-stocks-to-buy-in-q2-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/536dacc6-050b-4910-804d-d8217b74efe1" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2024-03-29" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(18) "General Investment" } } [1]=> array(7) { ["title_en"]=> string(63) "Hardly any impetus for Bristol-Myers Squibb shares (€48.6956)" ["snippet_en"]=> string(106) "There is currently little price movement in Bristol-Myers Squibb shares. The most recent price was $53.29." ["url"]=> string(89) "https://www.ariva.de/news/kaum-impulse-fr-die-bristol-myers-squibb-aktie-48-6956-11170106" ["image_url"]=> string(78) "https://images.businessradar.com/articles/01c96ea4-c9ae-4546-bc54-9009a65d5360" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-03-07" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(68) "The biotech $100-billion Club: Meet the 14 most valuable drug makers" ["snippet_en"]=> string(138) "Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow's breakthroughs." ["url"]=> string(75) "https://www.labiotech.eu/best-biotech/biotech-companies-highest-market-cap/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e5ed3a68-784f-4a3c-815d-3673c1eb3930" ["source"]=> string(12) "labiotech.eu" ["publication_date"]=> string(10) "2024-03-05" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" } } [3]=> array(7) { ["title_en"]=> string(43) "BMS: Related Party Transactions | Vietstock" ["snippet_en"]=> string(129) "Mr. Trinh Van Quyet manipulates the stock market? Mr. Trinh Van Quyet manipulates the stock market? Financial information portal-" ["url"]=> string(76) "https://vietstock.vn/2024/03/bms-giao-dich-voi-ben-lien-quan-830-1161087.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/543b45da-0f70-46b7-8ec5-99e4f47546a7" ["source"]=> string(12) "vietstock.vn" ["publication_date"]=> string(10) "2024-03-04" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" [2]=> string(26) "Related Party Transactions" } } [4]=> array(7) { ["title_en"]=> string(60) "The 3 Best Stocks Beginning Investors Can Buy: February 2024" ["snippet_en"]=> string(129) "Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article." ["url"]=> string(94) "https://investorplace.com/2024/02/the-3-best-stocks-beginning-investors-can-buy-february-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/83918bdc-ad3e-437b-8102-171f3e499100" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(11) { [0]=> string(18) "General Investment" [1]=> string(25) "Business Model Resilience" [2]=> string(15) "Market Movement" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(9) "Investors" [5]=> string(24) "Stock Research & Ratings" [6]=> string(18) "Expansion & Growth" [7]=> string(24) "Quarterly/Annual Figures" [8]=> string(12) "Stock Market" [9]=> string(18) "Financial Distress" [10]=> string(19) "Investment Requests" } } [5]=> array(7) { ["title_en"]=> string(80) "Bristol-Myers Squibb (NYSE:BMY) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(163) "Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4de830b8-96f1-41ad-9b3a-d3f1302099c4" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-02-18" ["categories"]=> array(5) { [0]=> string(11) "Acquisition" [1]=> string(15) "Market Movement" [2]=> string(24) "Stock Research & Ratings" [3]=> string(12) "Stock Market" [4]=> string(21) "Shareholders Feedback" } } [6]=> array(7) { ["title_en"]=> string(56) "Analyst: Positive Catalysts Can't Save This Pharma Stock" ["snippet_en"]=> string(85) "Bristol-Myers Squibb (BMY) was downgraded to "neutral" from "buy" by Redburn-Atlantic" ["url"]=> string(113) "https://www.schaeffersresearch.com/content/news/2024/02/06/analyst-positive-catalysts-cant-save-this-pharma-stock" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8bc42518-41cc-43ed-84cc-8d8f8bc935e0" ["source"]=> string(22) "schaeffersresearch.com" ["publication_date"]=> string(10) "2024-02-06" ["categories"]=> array(3) { [0]=> string(19) "Economic Conditions" [1]=> string(12) "Stock Market" [2]=> string(24) "Stock Research & Ratings" } } [7]=> array(7) { ["title_en"]=> string(35) "10 Blue-Chip Stocks At 52-Week Lows" ["snippet_en"]=> string(284) "In this piece, we will take a look at the ten blue chip stocks at 52 week lows. If you want to skip the latest stock market news, then you can take a look at the 5 Blue-Chip Stocks At 52-Week Lows. The end of January has provided the media and investors with crucial information [...]" ["url"]=> string(71) "https://uk.finance.yahoo.com/news/10-blue-chip-stocks-52-100410984.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/45ada533-a08b-4b07-8d8d-956e08518f0f" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-02-02" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" } } [8]=> array(7) { ["title_en"]=> string(63) "Short Interest in Bristol-Myers Squibb (NYSE:BMY) Drops By 7.4%" ["snippet_en"]=> string(258) "Bristol-Myers Squibb (NYSE:BMY - Get Free Report) saw a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 22,310,000 shares, a drop of 7.4% from the December 15th total of 24,100,000 shares." ["url"]=> string(82) "https://www.marketbeat.com/instant-alerts/nyse-bmy-options-data-report-2024-01-17/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5f567175-2149-40f1-90bb-539a8e237bd6" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-17" ["categories"]=> array(5) { [0]=> string(18) "General Investment" [1]=> string(21) "Financial Performance" [2]=> string(24) "Stock Research & Ratings" [3]=> string(12) "Stock Market" [4]=> string(13) "Credit Rating" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(75) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(32) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [25]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company